Pharma giants' to clash in court over biosimilar product dispute

Pfizer Inc. sued Johnson& Johnson Wednesday in the latest twist to the heated and protracted battle over biosimilar competition for a multibillion-dollar blockbuster medicine originally developed by Centocor. In its lawsuit filed at U.S. District Court in Philadelphia, Pfizer (NYSE: PFE) alleges that Johnson& Johnson ’s exclusionary contracts and other anticompetitive practices “have denied patients access to therapeutic options and undermined the benefits of robust price competition in the…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news